Eyelid cancers are not uncommon tumours and are usually basal cell or more rarely squamous cell in character. Their importance lies in their special situation since unlike cancer arising elsewhere in the skin they can by their natural progression or as a consequence of the effects of treatment cause impairment or even loss of vision. Although these tumours are 'malignant', death of the patient rarely results from failure of local control, unless the disease is very advanced or was mismanaged at the outset. In the case of squamous cell cancer, death may occasionally result from metastatic spread.
It should be an obvious ethical maxim that no patient should be submitted to a major surgical operation if an established and equally effective alternative non-surgical procedure is available. In the case of skin cancer generally and the lids in particular radiotherapy provides such an alternative since its curative value has been firmly established during the past 50 years. The reluctance of ophthalmologists to advise the use of radiant energy appears to relate to the calamities that first attended its use by the pioneer ophthalmologists at the beginning of this century. The story of their heritage of ocular disasters has been transmitted from generation to generation ignoring the fact that progress in radiotherapy has been such that under modern conditions most of the complications, particularly the more gruesomely destructive ones, can largely be avoided. In view of this the presentday tendency to submit patients suffering from lid neoplasms indiscriminately to simple excisional or plastic surgical procedures without considering an established altemative would seem unjustifiable.
This report on a series of 896 patients (Table I) usually easy and the response to radiation typical. In any event this proportion of the cases is small enough not to vitiate the conclusions drawn from this study. Of the 689 previously untreated patients a number had had an excision biopsy before radiotherapy: some 8o patients had had an attempted primary excision but were promptly referred for postoperative radiotherapy because the pathological report showed that removal had been incomplete.
The recurrent cases comprise those patients whose symptoms recurred after receiving some form of surgery or radiotherapy at other hospitals (I04 excisions; three excision and radiotherapy; five radiotherapy; five excision and plastic repair). These patients were referred to the Royal Marsden Hospital for treatment after frank recurrence 'had taken place. The patients seen and not treated include those who were referred for an opinion, some who were advised to have surgery, and a few patients who refused treatment. Tables IIa, b show the regional distribution of the tumours in relation to their sex incidence. The well-known preponderance of tumours on the lower lid and inner canthus is well shown. The basal cell carcinomas are approximately io times more common than the squamous carcinomas but the latter form a higher proportion of the tumours of the upper lid and outer canthus. The sex ratios are male/female: 1-23 for the basal cell carcinomas and 2-93 for the squamous carcinomas. Table III shows the age incidence illustrating the fact that most of the patients are elderly. Fig. 2 it can be seen that in early lesions the lashes provide a reasonable baseline for identification. In the ciliary site the tumour is above the lashes or the lashes bisect it equally, whereas in the tarsal lesion the lash margin may be free or if it is involved the bulk of the tumour is below this line. The separation between tarsal and orbital lesions rarely presents problems although when both parts of the lid are affected the bulk of the tumour is usually on one or other side of the orbitopalpebral sulcus. Loss of lashes in relation to the tumour may occur with both tarsal and ciliary lesions, but usually the remaining lashes help in identifying the level of origin of a given tumour.
Figs 7a, b (Mustarde' and Jones, I970) show schematically the direction and site of insertion of the main fasciculi of the orbicularis oculi muscle.
It is not too difficult to imagine the similarity between the distribution of these sphincteric fasciculi and the sites of origin of the overlying skin tumours. Equally the frequency with which the inner canthus and lower lid are involved seems to be reflected in the manner and site of insertion of the muscle fibres. A classification for skin cancer has been recommended by the Committee and is meant to be applicable to tumours of the eyelids. In practice its implementation is difficult since it is dependent on tumour measurements and the dimensions it selects (2 and 5 cm) as a fbasis for classification are not readily relevant to the average lid tumour, Table VI .
In this series of cases the precise dimensions of the tumour were not routinely recorded since the site and extent of the lid involvement was expressed in topographical terms so as to indicate the manner and direction of tumour spread. However, some idea of the size of the tumour can be obtained from the maximum dimension of the field size used in treatment (this usually included a minimum margin of 5 mm of apparently normal skin surrounding the lesion) (Halman and Britten, I960) . Tables VIIa, b show the distribution of the basal cell and squamous cell carcinomata according to the field sizes used in treatment. The tumour of 3 cm or less would presumably correspond to the Ti group, the 3 to [3] [4] [5] [6] [7] [8] [9] 
Epiphora (io per cent)
The possible occurrence of postradiation epiphora is frequently advanced as an argument against the use of radiotherapy. However, the obliteration or loss of the upper punctum occasions no problem: only when the lower punctum and canaliculus are stenosed or destroyed may epiphora occur. Mustarde and Jones (1970) in discussing the reconstructive surgery of the medial canthus point out that it is possible to remove the lacrimal passages completely without epiphora. After such an event epiphora will occur only in the presence of conditions giving rise to excessive tear formation. These are listed as being high wind, undue exposure of the conjunctiva, and in particular ectropion and also inflammatory conditions involving the lid margin, conjunctiva, cornea, or lacrimal sac. These observations are supported by the events after radiation obliteration of the lacrimal passages. Only a small proportion of the patients in this This ability of the eye to accommodate itself to loss of the lacrimal passages means that attempts to maintain the patency of the punctum during or after radiotherapy, by irrigation, intermittent dilatation, the insertion of various kinds of dilator or operation are unnecessary. Efforts should rather be directed to ensuring that every cause of irritation that might give rise to a reflex increase in tear production should be sought and eliminated.
There is one factor that operates to the advantage of the patient with postradiation as opposed to postsurgical epiphora and that is that in many cases the epiphora appears to be self-limiting, tending to subside spontaneously within a year of treatment. The reason for this fortunate event is that radiation not only produces stenosis of the punctum but also destroys some of the secretory glands of the lid and conjunctiva so that there is a reduction in the total quantity of tears produced. At some point the impaired secretory mechanism and the damaged drainage system enter into compensatory equilibrium and the patient's eye no longer weeps.
OTIIER COMPLICATIONS, Table XI Keratinization of the conjunctival mucosa occurred in 5 6 per cent of cases. When this affected the lower lid problems could be avoided by regular removal of the keratin plaque and most patients can be taught to do this themselves. In the upper lid the keratin plaque is a potential menace to the cornea and a contact lens may be required to avoid corneal damage. Fortunately in recent years keratinization is less likely because of modifications in radiation technique whereby intense reactions are avoided.
Lid necrosis has occurred in patients with moderately atrophic skin changes or those with surgical scars. As a rule these necroses seem to occur in summer after exposure to an intense and unaccustomed degree of sunlight. The avoidance of bad scars, warning the patients against direct B -ĩ . exposure of the lids to intense sunlight, and the use of barrier creams all help. These sunlightinduced necroses heal readily with the application of a corticosteroid ointment once the solar-exposure factor is removed. The corneal complications encountered were not due to direct irradiation of the cornea since in nearly all cases complete shielding of the cornea was achieved. Most of the comeal complications were due to exposure or irritation from secondary changes in the lid. The radiation cataracts occurred in patients treated by gamma radiation, usually in the form of a radon seed implant. In no case was it found necessary to deal with the cataract surgically. Of the three cases where the eye was lost, in two the eye was removed before the patient was referred for radiotherapy and in the third case a useless eye was removed because of involvement by uncontrolled disease.
Prevention of complications GENERAL MEASURES
Patients undergoing the irradiation of a lid tumour inevitably develop a radiation reaction in the treated area. While this lid reaction ultimately subsides and is generally followed by few complications, the related bulbar conjunctiva and the cornea may, as already noted, be secondarily affected even though total protection of these tissues against irradiation has been provided. In addition many of the patients in the age groups concerned have incidental ocular problems requiring skilled care while the patient is undergoing radiotherapy. Because of this there is imperative need for ophthalmological control and care of the patient during treatment and the ophthalmologist has a vital part to play in any radiation unit dealing with these cases if unnecessary complications are to be avoided.
CONTRAINDICATIONS TO RADIOTHERAPY
The misuse of radiotherapy is understandable since it is a non-operative procedure readily available and easily applied. However, if complications are to be eliminated or reduced in frequency then the radiotherapist must be on his guard not to be enticed into treating a patient in circumstances where complications are inevitable or when treatment is accompanied by a high risk of postradiation damage. In these circumstances it is clearly better for the patient to submit to alternative, nonradiational methods. If no alternative is available or if available would entail removal of the eye then the radiation risks may be accepted as the lesser of two evils but this should be done only after a full discussion with both the patient and his doctors.
The following may be accepted as contraindications to radiotherapy:
Recurrence after previous treatment Recurrent cases, whether the previous treatment be surgical or Bone invasion Radiotherapy is rarely successful in eradicating a tumour which has invaded bone. The advanced rodent ulcer accompanied by orbital bone invasion is best treated by a preliminary course of radiation followed by radical surgery.
A very small lesion remote from the canthus and lid margins Radiotherapy should be avoided in cases in which a biopsy excision would adequately remove the tumour.
TECHNICAL MEASURES
The technical steps the radiotherapist can take towards reducing the complications affecting the lids, conjunctiva, and the eye relate to the selection of apparatus and the dose and time factors of the treatment. Unwelcome cosmetic sequelae are more likely where radiation energies of 6o kV or less are used and ocular complications are more likely when gamma-ray sources are implanted near the eye.
The intensity of the radiation reaction, the incidence of mucosal keratinization, and the cosmetic quality of the radiation scar can all be favourably influenced by attention to the fractionation of the dose and the length of the overall treatment time. It is difficult to determine the part that surgery should play in the treatment of these tumours since a survey of the surgical literature, particularly publications emanating from plastic surgical sources, are devoted almost exclusively to detailed accounts of surgical techniques. Any prolonged acquaintance with the treatment of malignant disease will demonstrate that cancer is no respecter of surgical expertise and for any given surgical procedure for lid cancer to be acceptable careful objective evaluation is necessary. If the rigid standards adopted by radiotherapists are to be followed it is essential that the description of any given operation be accompanied by its contraindications, complications, and the success rate achieved over at least a five-year period of observation. Nevertheless it must be accepted that in spite of the reliable results and obvious advantages of radiotherapy some cases are better treated by surgery particularly those contraindicating radiotherapy.
Any further scope for surgery should, assuming the patient is fit for operation, depend on the tumour size and situation and hence the simplicity or complexity of the operation needed.
If the size of tumour in this series (Tables VIIa, b) is taken as representative it will be seen that of the basal cell carcinomas approximately one-third of the lid tumours and two-thirds of the inner canthus tumours would fall into category Ti of the UICC system of classification. This means that allowing for a 5 mm margin of normal tissue these tumours were 2 cm or less in diameter and therefore presumably suitable for an operation not requiring plastic lid reconstruction (Mustarde and Jones, 1970) . It should be noted that it is precisely these early cases that give the best results and fewest complications with radiation treatment. However, the remaining patients, namely the majority, would require excision and lid reconstruction with all that that entails by way of availability of the requisite surgical skills, the surgical risks for the elderly patient, to which must be added the economic disadvantages of surgical as opposed to radiotherapeutic treatment.
As 
